Phase I/II study of the oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC). This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers Symposium.
Sitra were then spared additional heartbreak in the fourth minute of second-half injury time when a red card shown to Saudi professional Rayan Fourgi was rescinded by the referee. Fourgi was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results